Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 21.54
(0.0%)
USD 21.54
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 50.4 Billion JPY | 19.04% |
| 2023 | 42.33 Billion JPY | 6.55% |
| 2022 | 35.81 Billion JPY | 12.77% |
| 2021 | 29.89 Billion JPY | -6.25% |
| 2020 | 28.79 Billion JPY | 13.42% |
| 2019 | 22.85 Billion JPY | 4.99% |
| 2018 | 22.87 Billion JPY | 20.92% |
| 2017 | 20.81 Billion JPY | -2.58% |
| 2016 | 20.91 Billion JPY | -99.04% |
| 2015 | 20.32 Billion JPY | -12.08% |
| 2014 | 23.31 Billion JPY | 13.99% |
| 2013 | 20.45 Billion JPY | 7.26% |
| 2012 | 19.44 Billion JPY | -33.73% |
| 2011 | 18.24 Billion JPY | 0.56% |
| 2010 | 18.34 Billion JPY | 3.78% |
| 2009 | 15.4 Billion JPY | 0.82% |
| 2008 | 17.36 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - JPY | 16420.83% |
| 2024 Q4 | 5.12 Billion JPY | -64.79% |
| 2024 Q3 | 116.79 Million JPY | 36.01% |
| 2024 Q2 | 77.21 Million JPY | -15.65% |
| 2024 Q1 | 93.86 Million JPY | 155.15% |
| 2023 Q3 | 103.19 Million JPY | 45.9% |
| 2023 Q4 | 57.03 Million JPY | -44.72% |
| 2023 Q1 | 75.12 Million JPY | 15.88% |
| 2023 Q2 | 70.72 Million JPY | -5.85% |
| 2023 FY | - JPY | 6.55% |
| 2022 Q3 | 101.27 Million JPY | 25.19% |
| 2022 Q4 | 64.82 Million JPY | -35.99% |
| 2022 FY | - JPY | 12.77% |
| 2022 Q1 | 68.54 Million JPY | 10.41% |
| 2022 Q2 | 80.9 Million JPY | 18.02% |
| 2021 Q3 | 6.42 Billion JPY | -10.06% |
| 2021 Q2 | 7.14 Billion JPY | 80.18% |
| 2021 FY | - JPY | -6.25% |
| 2021 Q1 | 3.96 Billion JPY | -4.62% |
| 2021 Q4 | 62.08 Million JPY | -99.03% |
| 2020 FY | - JPY | 13.42% |
| 2020 Q3 | 7.22 Billion JPY | 3.29% |
| 2020 Q4 | 4.15 Billion JPY | -42.41% |
| 2020 Q1 | 3.95 Billion JPY | 185.22% |
| 2020 Q2 | 6.99 Billion JPY | 76.69% |
| 2019 Q4 | 1.38 Billion JPY | -78.76% |
| 2019 FY | - JPY | 4.99% |
| 2019 Q3 | 6.53 Billion JPY | 11.11% |
| 2019 Q2 | 5.87 Billion JPY | 10.49% |
| 2019 Q1 | 5.32 Billion JPY | 69.59% |
| 2018 Q2 | 5.19 Billion JPY | 43.12% |
| 2018 Q1 | 3.62 Billion JPY | 19.69% |
| 2018 FY | - JPY | 20.92% |
| 2018 Q4 | 3.13 Billion JPY | -55.38% |
| 2018 Q3 | 7.03 Billion JPY | 35.35% |
| 2017 Q2 | 4.42 Billion JPY | 79.5% |
| 2017 FY | - JPY | -2.58% |
| 2017 Q1 | 2.46 Billion JPY | -21.8% |
| 2017 Q4 | 3.03 Billion JPY | -50.92% |
| 2017 Q3 | 6.17 Billion JPY | 39.68% |
| 2016 FY | - JPY | -99.04% |
| 2016 Q2 | 5.4 Billion JPY | 146.26% |
| 2016 Q4 | 3.15 Billion JPY | -33.73% |
| 2016 Q1 | 2.19 Billion JPY | -50.56% |
| 2016 Q3 | 4.75 Billion JPY | -11.99% |
| 2015 Q4 | 4.43 Billion JPY | 9.36% |
| 2015 Q2 | 4.58 Billion JPY | 300.09% |
| 2015 Q1 | 1.14 Billion JPY | -70.03% |
| 2015 Q3 | 4.05 Billion JPY | -11.42% |
| 2015 FY | - JPY | -12.08% |
| 2014 Q4 | 3.82 Billion JPY | -33.39% |
| 2014 FY | - JPY | 13.99% |
| 2014 Q3 | 5.73 Billion JPY | 23.86% |
| 2014 Q2 | 4.63 Billion JPY | 44.49% |
| 2014 Q1 | 3.2 Billion JPY | -18.36% |
| 2013 Q1 | 2.93 Billion JPY | -77.67% |
| 2013 Q2 | 3.09 Billion JPY | 5.31% |
| 2013 Q3 | 5.05 Billion JPY | 63.25% |
| 2013 FY | - JPY | 7.26% |
| 2013 Q4 | 3.92 Billion JPY | -22.27% |
| 2012 FY | - JPY | -33.73% |
| 2012 Q1 | 3.04 Billion JPY | -79.54% |
| 2012 Q2 | 3.59 Billion JPY | 18.08% |
| 2012 Q3 | 4.91 Billion JPY | 36.8% |
| 2012 Q4 | 13.15 Billion JPY | 167.75% |
| 2011 Q1 | 3.38 Billion JPY | -76.61% |
| 2011 Q4 | 14.86 Billion JPY | 146.02% |
| 2011 Q3 | 6.04 Billion JPY | 35.89% |
| 2011 Q2 | 4.44 Billion JPY | 31.22% |
| 2011 FY | - JPY | 0.56% |
| 2010 Q1 | 4.61 Billion JPY | -67.37% |
| 2010 FY | - JPY | 3.78% |
| 2010 Q4 | 14.48 Billion JPY | 160.69% |
| 2010 Q3 | 5.55 Billion JPY | 41.21% |
| 2010 Q2 | 3.93 Billion JPY | -14.68% |
| 2009 Q2 | 2.91 Billion JPY | 0.0% |
| 2009 FY | - JPY | 0.82% |
| 2009 Q4 | 14.13 Billion JPY | 139.67% |
| 2009 Q3 | 5.89 Billion JPY | 102.09% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -77.49 Thousand USD | 65042040.896% |
| Bruush Oral Care Inc. | -4.9 Million USD | 1027307.203% |
| CCA Industries, Inc. | -259.14 Thousand USD | 19449282.302% |
| DSwiss, Inc. | 20 Thousand USD | -251979702.02% |
| EOS, Inc. | -592.2 Thousand USD | 8510892.788% |
| Greyson International, Inc. | -75.91 Thousand USD | 66395831.788% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -42000733.333% |
| Infusion Brands International, Inc. | -6.17 Million USD | 815935.968% |
| Mandom Corporation | 44.26 Million USD | -113774.077% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -597.89 Thousand USD | 8429855.107% |
| Oliveda International, Inc. | -1.18 Million USD | 4242119.228% |
| PacificHealth Laboratories, Inc. | -430 Thousand USD | 11721208.274% |
| Prosperous Future Holdings Limited | -19.68 Million USD | 256124.586% |
| PURE Bioscience, Inc. | -3.04 Million USD | 1654218.805% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -476.51 Thousand USD | 10577012.988% |
| Sentient Brands Holdings Inc. | -246.98 Thousand USD | 20406932.914% |
| Sunset Capital Assets, Inc. | -190.12 Thousand USD | 26509222.849% |
| The Stephan Co. | -124 Thousand USD | 40646067.742% |
| Turner Valley Oil & Gas, Inc. | -115.2 Thousand USD | 43747930.012% |
| Winning Brands Corporation | -267.95 Thousand USD | 18809952.584% |
| Warpaint London PLC | 26.02 Million USD | -193533.793% |
| Zoono Group Limited | -5.41 Million USD | 931192.573% |
| Zurvita Holdings, Inc. | -79.68 Thousand USD | 63251191.813% |